Serina Therapeutics, Inc. (SER)
NYSE: SER · Pharmaceutical Preparations · Huntsville, AL · filing with the SEC since 2017
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
| Report filed | Mar 25, 2026 | Mar 24, 2025 | Mar 22, 2024 | Mar 31, 2023 | Mar 29, 2022 | Mar 31, 2021 | Mar 30, 2020 | Apr 1, 2019 | · |
| Revenue | 130 | 56 | 3,153r | 34 | 144 | 361r | 1,728 | 1,396 | 1,404 |
| Cost of revenue | · | · | 40 | 13 | 19 | 26r | 244 | 364 | 168 |
| Gross profit | · | · | 102 | 21 | 125 | 335r | 1,484 | 1,032 | 1,236 |
| Research and development | 13,155 | 7,480 | 2,388r | 1,025 | 1,456 | 3,714r | 5,904 | 5,830 | 5,784 |
| General and administrative | 10,997 | 9,624 | 3,894r | 5,971 | 6,708 | 6,721r | 8,139 | 5,647 | 3,869 |
| Total operating expenses | 24,152 | 17,104 | 6,282r | 6,996 | 8,164 | 10,435r | 14,043r | -12,277r | 9,653 |
| Operating income | -24,022 | -17,048 | -3,129r | -6,975 | -7,933 | -10,100r | -12,559 | -11,245 | -6,663 |
| Interest expense | 213 | 526 | 558 | 3,335 | 1,097 | · | · | · | · |
| Interest income (expense), net | · | · | · | · | -1,097 | -404r | 29 | 116 | -12 |
| Other income (expense), net | 51 | 228 | · | · | 448 | 105r | 294 | · | · |
| Total non-operating income (expense) | 4,825 | 5,841 | 8,398r | -3,547 | -649 | -299r | 323 | 3,514 | 26 |
| Income before income taxes | -19,197 | -11,207r | 5,269r | 10,500 | 8,700r | -11,126 | -12,236 | -7,731 | · |
| Income tax expense | 18 | 0 | 0 | · | · | -150 | 148 | · | · |
| Income from continuing operations | · | · | · | -10,462 | -8,579 | -10,394 | · | · | · |
| Income from discontinued operations | · | · | · | · | -103 | -727 | · | · | · |
| Net income including non-controlling interests | -19,215 | -11,207 | 5,269r | -10,522 | -8,685 | -10,976 | -12,384 | -7,731 | -6,637 |
| Net income to non-controlling interests | -33 | -66 | 0r | -60 | -3 | -111 | -230 | -229 | -57 |
| Net income | -19,182 | -11,141 | 5,269r | -10,462 | -8,675 | -10,865 | -12,154 | -7,502 | -6,580 |
| Preferred dividends | 254 | 0 | · | · | · | · | · | · | · |
| Net income to common shareholders | -19,436 | -11,141 | 5,269 | · | 8,579 | 10,394 | · | · | · |
| Earnings per share, basic | -1.91 | -1.51 | 2.36r | -9.70r | -0.23 | · | · | · | · |
| Earnings per share, diluted | -1.91 | -1.51 | 0.73r | -9.70 | · | · | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -0.23 | -0.29 | -0.33 | -0.21 | -0.21 |
| Weighted average shares, basic | 10,190,000 | 7,359,000 | 2,235,000r | 1,079r | 37,886,000 | · | · | · | · |
| Weighted average shares, diluted | 10,190,000 | 7,359,000 | 7,351,000r | 1,079 | · | · | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 37,886,000 | 37,669,000 | 37,271,000 | 34,914,000 | 30,644,000 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpenseInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitIncome from continuing operations profit from the businesses it keeps
us-gaap:IncomeLossFromContinuingOperationsIncome from discontinued operations profit or loss from businesses it sold or closed
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossPreferred dividends paid to preferred holders before common shareholders
us-gaap:PreferredStockDividendsIncomeStatementImpactNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted